Status | Study |
Recruiting |
Study Name: International Registry Study of Neutral Lipid Storage Disease (NLSD) / Triglyceride Deposit Cardiomyovasculopathy (TGCV) and Related Diseases Condition: Neutral Lipid Storage Disease Date: 2016-08-04 |
Recruiting |
Study Name: Clinical Study on the Safety of CNT-02 for TGCV and NLSD-M Condition: Primary Triglyceride Deposit Cardiomyovasculopathy (TGCV) Neutral Lipi Date: 2016-07-06 Interventions: Dietary Supplement: CNT-02 Each subject will take 2.0g of the investigational product orally 3 times a d |
Completed |
Study Name: The Effect of Fibrate Therapy in Two Patients With Neutral Lipid Storage Disease With Myopathy (NLSDM) Condition: Neutral Lipid Storage Disease Date: 2012-01-16 Interventions: Drug: Fibrate treatment Patients will receive a dosage of 400mg Bezafibrate every day during 28 weeks |